Polyrizon Ltd. (PLRZ) Stock Price, Quote & News - Mboum

Company Profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorp...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 9 374 0120

Website: www.polyrizon-biotech.com

Address:

5 Ha-Tidhar Street, Ra'anana, Israel

Joshr1371 Oct. 24 at 11:57 PM

$PLRZ “N” for Not today 🤪

0 · Reply

UnicornProfits Oct. 24 at 8:33 PM

What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $NEON $LAC $QURE $PLRZ bought dips

1 · Reply

LowFloatScanner_ Oct. 24 at 8:29 PM

What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $BLMZ $PLRZ $BTCT $BTOG crypto

0 · Reply

Stock_tits1 Oct. 23 at 10:18 PM

$PLRZ Maybe

0 · Reply

alert716 Oct. 23 at 8:27 PM

$PLRZ news soon !! its do for one 🤑🤑🤑🤑 $SCNX $SGBX $BLMZ $IXHL

1 · Reply

Tbirdyguy Oct. 23 at 11:58 AM

$PLRZ wow all gains lost and right back to 1.06.

0 · Reply

ggez3232 Oct. 23 at 1:50 AM

$PLRZ added more this morning

0 · Reply

BuyRightAndWaitForProfit Oct. 22 at 12:48 PM

1 · Reply

ibaian Oct. 21 at 11:22 PM

$PLRZ According to the World Health Organization (WHO), epilepsy is a neurological condition affecting about 50 million people worldwide. Many existing therapies fail to provide adequate control of acute repetitive seizures and may come with undesirable adverse effects. The global acute repetitive seizures market size was estimated at USD 3.15 billion in 2024 and is projected to grow at a CAGR of 12.7% from 2025 to 2030.

1 · Reply

ibaian Oct. 21 at 11:21 PM

$PLRZ Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

0 · Reply

Latest News on PLRZ

Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy

Oct 6, 2025, 8:21 AM EDT - 19 days ago

Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy

Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker

Sep 19, 2025, 8:15 AM EDT - 5 weeks ago

Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

Sep 12, 2025, 7:26 AM EDT - 6 weeks ago

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

Polyrizon Regains Compliance with Nasdaq Listing Requirements

Aug 14, 2025, 8:14 AM EDT - 2 months ago

Polyrizon Regains Compliance with Nasdaq Listing Requirements

Polyrizon Retains Nasdaq Listing Following Hearings Panel

Jul 15, 2025, 7:55 AM EDT - 3 months ago

Polyrizon Retains Nasdaq Listing Following Hearings Panel

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Jun 12, 2025, 7:32 AM EDT - 4 months ago

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Polyrizon Announces Receipt of Nasdaq Delisting Notice

May 23, 2025, 4:15 PM EDT - 5 months ago

Polyrizon Announces Receipt of Nasdaq Delisting Notice

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

May 21, 2025, 7:10 AM EDT - 5 months ago

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

May 13, 2025, 7:45 AM EDT - 5 months ago

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Apr 25, 2025, 7:37 AM EDT - 6 months ago

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Apr 11, 2025, 4:15 PM EDT - 7 months ago

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Apr 2, 2025, 9:05 AM EDT - 7 months ago

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Apr 1, 2025, 4:09 PM EDT - 7 months ago

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Polyrizon Ltd. Announces $17.0 Million Private Placement

Mar 31, 2025, 9:32 AM EDT - 7 months ago

Polyrizon Ltd. Announces $17.0 Million Private Placement

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Mar 27, 2025, 8:25 AM EDT - 7 months ago

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Mar 25, 2025, 4:04 PM EDT - 7 months ago

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Mar 14, 2025, 8:35 AM EDT - 8 months ago

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Mar 13, 2025, 7:51 AM EDT - 8 months ago

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Mar 11, 2025, 4:27 PM EDT - 8 months ago

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Mar 10, 2025, 7:47 AM EDT - 8 months ago

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

Jan 30, 2025, 5:55 AM EST - 9 months ago

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Jan 23, 2025, 6:40 AM EST - 9 months ago

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Dec 30, 2024, 6:25 AM EST - 10 months ago

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Dec 19, 2024, 7:22 AM EST - 11 months ago

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Dec 18, 2024, 6:25 AM EST - 11 months ago

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Dec 13, 2024, 6:25 AM EST - 11 months ago

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Dec 2, 2024, 8:02 AM EST - 11 months ago

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

Oct 30, 2024, 1:50 PM EDT - 1 year ago

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Oct 30, 2024, 10:28 AM EDT - 1 year ago

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

Oct 28, 2024, 7:02 PM EDT - 1 year ago

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

Joshr1371 Oct. 24 at 11:57 PM

$PLRZ “N” for Not today 🤪

0 · Reply

UnicornProfits Oct. 24 at 8:33 PM

What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $NEON $LAC $QURE $PLRZ bought dips

1 · Reply

LowFloatScanner_ Oct. 24 at 8:29 PM

What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $BLMZ $PLRZ $BTCT $BTOG crypto

0 · Reply

Stock_tits1 Oct. 23 at 10:18 PM

$PLRZ Maybe

0 · Reply

alert716 Oct. 23 at 8:27 PM

$PLRZ news soon !! its do for one 🤑🤑🤑🤑 $SCNX $SGBX $BLMZ $IXHL

1 · Reply

Tbirdyguy Oct. 23 at 11:58 AM

$PLRZ wow all gains lost and right back to 1.06.

0 · Reply

ggez3232 Oct. 23 at 1:50 AM

$PLRZ added more this morning

0 · Reply

BuyRightAndWaitForProfit Oct. 22 at 12:48 PM

1 · Reply

ibaian Oct. 21 at 11:22 PM

$PLRZ According to the World Health Organization (WHO), epilepsy is a neurological condition affecting about 50 million people worldwide. Many existing therapies fail to provide adequate control of acute repetitive seizures and may come with undesirable adverse effects. The global acute repetitive seizures market size was estimated at USD 3.15 billion in 2024 and is projected to grow at a CAGR of 12.7% from 2025 to 2030.

1 · Reply

ibaian Oct. 21 at 11:21 PM

$PLRZ Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

0 · Reply

Deblitorator Oct. 21 at 1:33 PM

$PLRZ Won't stay this low for long. $2+ at the bare minimum within a few weeks. A+ setup all around.

1 · Reply

PumpThatMother Oct. 21 at 10:30 AM

$PLRZ Today?

1 · Reply

Slitherin Oct. 21 at 9:17 AM

$PLRZ this always go parabolic and they put news often. I’m adding more

1 · Reply

ggez3232 Oct. 21 at 8:43 AM

0 · Reply

ggez3232 Oct. 21 at 3:53 AM

$PLRZ i told you guys and let me tell you again buy before it's too late...

0 · Reply

PumpThatMother Oct. 20 at 11:18 PM

$PLRZ hopefully news soon

0 · Reply

PumpThatMother Oct. 20 at 9:22 PM

$PLRZ this is good she keep coming back here to 1.17 💪

0 · Reply

crabhunter Oct. 20 at 9:20 PM

$PLRZ what? 1.17 AH... but in again today for 1.146.... opne of these days

0 · Reply

BULLonROIDS Oct. 20 at 7:59 PM

$PLRZ 3X their valuation in cash with no liabilities or debt. Easy 3x from here.

0 · Reply

PumpThatMother Oct. 20 at 6:35 PM

$PLRZ 1.16.. I need some excitement here lol

1 · Reply

PumpThatMother Oct. 20 at 5:41 PM

$PLRZ why so quiet in here it says 4500 watchers u guys feel good about it

0 · Reply

PumpThatMother Oct. 20 at 3:03 PM

$PLRZ this week hopefully we break 1.27 then off to the races

1 · Reply